Adaptimmune Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $867k | 6.7M | 0.13 |
| 2025-06-30 | $15k | 63k | 0.24 |
| 2025-03-31 | $200k | 1.0M | 0.20 |
| 2024-12-31 | $76k | 142k | 0.54 |
| 2024-09-30 | $1.7k | 1.8k | 0.95 |
| 2024-06-30 | $1.8k | 1.8k | 0.98 |
| 2024-03-31 | $311k | 197k | 1.58 |
| 2023-12-31 | $20k | 25k | 0.79 |
| 2023-09-30 | $22k | 28k | 0.78 |
| 2023-06-30 | $29k | 31k | 0.93 |
| 2023-03-31 | $29k | 27k | 1.09 |
| 2022-12-31 | $35k | 24k | 1.46 |
| 2022-09-30 | $0 | 2.0k | 0.00 |
| 2022-06-30 | $16k | 4.7k | 3.33 |
| 2022-03-31 | $18k | 5.5k | 3.33 |
| 2021-12-31 | $45k | 17k | 2.70 |
| 2021-09-30 | $84k | 16k | 5.41 |
| 2021-06-30 | $75k | 14k | 5.41 |
| 2021-03-31 | $998k | 188k | 5.31 |
| 2020-12-31 | $0 | 182k | 0.00 |
| 2020-09-30 | $1.8M | 125k | 14.29 |
| 2020-06-30 | $999 | 70 | 14.29 |
| 2020-03-31 | $14k | 5.1k | 2.79 |
| 2019-12-31 | $0 | 6.2k | 0.00 |
| 2019-09-30 | $0 | 70 | 0.00 |
| 2019-06-30 | $32k | 8.1k | 3.96 |
| 2019-03-31 | $24k | 5.5k | 4.39 |
| 2018-12-31 | $44k | 7.6k | 5.81 |
| 2018-09-30 | $1.6M | 118k | 13.58 |
| 2018-06-30 | $137k | 12k | 11.78 |
| 2018-03-31 | $38k | 3.4k | 11.17 |
| 2017-12-31 | $0 | 5.9k | 0.00 |
| 2017-09-30 | $12k | 1.5k | 8.00 |
| 2017-06-30 | $9.0k | 2.0k | 4.50 |
| 2017-03-31 | $4.0k | 772 | 5.18 |
| 2016-12-31 | $3.0k | 774 | 3.88 |
| 2016-09-30 | $23k | 3.2k | 7.17 |
| 2015-12-31 | $62k | 5.2k | 12.01 |
| 2015-09-30 | $22k | 1.9k | 11.82 |